[1]
Cao, C. et al. 2012. Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials. Acta Oncologica. 51, 2 (Feb. 2012), 151–156. DOI:https://doi.org/10.3109/0284186X.2011.631579.